| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Canada | 2 | |
| #4 | New Zealand | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Hong Kong | 1 | |
| #7 | Japan | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Thomson Helen | 6 |
| #2 | Ward Larry D | 6 |
| #3 | Brown Michael Paul | 6 |
| #4 | Howley Paul Michael | 6 |
| #5 | Kent Stephen | 3 |
| #6 | Ramshaw Ian Allister | 3 |
| #7 | Boyle David Bernard | 2 |
| #8 | Bernard Boyle David | 2 |
| #9 | Allister Ramshaw Ian | 1 |
| #10 | Stephen Kent | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2004281298A1 | Poxvirus vector encoding retrovirus (eg HIV) and cytokine | |
| CA2542155A1 | Poxvirus vector encoding retrovirus (eg hiv) and cytokine | |
| WO2005019464A1 | Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer | |
| AU2004202112A1 | Avipox Vector Coding a HIV Antigen and a Cytokine | |
| EP1129177A1 | Avipox vector coding an hiv antigen and gamma-interferon |